Indian Vaccine Market Report and Forecast 2017-2022



Over the years, India has emerged as one of the leading manufacturers of vaccines worldwide, and supplies large quantities of basic and advanced vaccines to nearly 150 countries. Currently, around 70% of the total volume of the vaccines manufactured is exported while the rest is utilised domestically. According to a new report by IMARC titled “Indian Vaccine Market Report and Forecast 2017-2022”, the Indian vaccine market reached a value of around INR 59 Billion in 2016, growing at a CAGR of nearly 18% during 2009-2016. 

The strong growth of the market can be attributed to numerous favourable factors. One of the primary forces that is stimulating the market growth is the increasing investments in research and development (R&D) by government funding agencies like the Department of Biotechnology, the Indian Council of Medical Research, and the Ministry of Health and Family Welfare. The launch of the Universal Immunization Program (UIP) aimed at increased immunization coverage against vaccine preventable diseases in the country, has also significantly added to the market growth. Moreover, with advancement in technology, the vaccine production capacity along with cold chain storage facilities have also been improved. Besides this, the advent of a number of privately owned firms in India have positively transformed the industry. These firms have been making efforts to bring low cost solutions and are increasingly shifting their focus on innovation so as to increase their revenues. Owing to these factors, India has emerged as a global vaccine manufacturing hub.
 
The report has segmented the Indian vaccine market on the basis of vaccine type. Currently, oral polio vaccine accounts for the majority of the market share, followed by rabies vaccines. The report has also analysed the competitive landscape and provides the profiles of the key players operating in the market. Some of the major players include Sanofi Aventis, Pfizer, Novartis, Serum Institute and Panacea Biotech.

This report provides a deep insight into the Indian vaccine industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, pricing analysis, etc. The report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Indian vaccine industry in any form.


Key Vaccines Covered in the Report

BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, DPT, Polio, MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV


Focus of the Analysis for Each Vaccine

  • Vaccine Overview 
  • Historical and Current Market Trends
  • Market Breakup by Prescriber
  • Market Breakup by Public and Private Sector
  • Market Outlook
     

1    Preface
2     Introduction and Methodology

    2.1 Objectives of the study
    2.2 Stakeholders
    2.3 Data Sources
       2.3.1 Primary Sources
       2.3.2 Secondary Sources
    2.4 Market Estimation
       2.4.1 Bottom-Up Approach
       2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Indian Vaccine Industry
    5.1    Market Overview
    5.2    Market Performance
       5.2.1 Volume Trends
       5.2.2 Value Trends
    5.3    Market Breakup by Segment
    5.4.    Market Forecast
       5.4.1 Volume Trends
       5.4.2 Value Trends
6    Market Analysis of Various Monovalent and Combined Vaccines
    6.1 BCG Vaccine Market
       6.1.1 Vaccine Overview 
        6.1.2 Market Performance
        6.1.3 Market Breakup by Prescriber
        6.1.4 Market Breakup by Public and Private Sectors
        6.1.5 Market Forecast
    6.2 HIB Vaccine Market
        6.2.1 Vaccine Overview 
        6.2.2 Market Performance
        6.2.3 Market Breakup by Prescriber
        6.2.4 Market Breakup by Public and Private Sectors
        6.2.5 Market Forecast
    6.3 Influenza Vaccine Market
        6.3.1 Vaccine Overview and Epidemiology
        6.3.2 Market Performance
        6.3.3 Market Breakup by Prescriber
        6.3.4 Market Breakup by Public and Private Sectors
        6.3.5 Market Forecast     
   6.4 Varicella Vaccine Market
        6.6.1 Vaccine Overview and Epidemiology
        6.6.2 Market Performance
        6.6.3 Market Breakup by Prescriber
        6.6.4 Market Breakup by Public and Private Sectors
        6.6.5 Market Forecast
   6.5 Typhoid Vaccine Market
        6.5.1 Vaccine Overview and Epidemiology
        6.5.2 Market Performance
        6.5.3 Market Breakup by Prescriber
        6.5.4 Market Breakup by Public and Private Sectors
        6.5.5 Market Forecast
    6.6 Japanese Encephalitis Vaccine Market
        6.6.1 Vaccine Overview and Epidemiology
        6.6.2 Market Performance
        6.6.3 Market Breakup by Prescriber
        6.6.4 Market Breakup by Public and Private Sectors
        6.6.5 Market Forecast
    6.7 Measles Vaccine Market
        6.7.1 Vaccine Overview and Epidemiology
        6.7.2 Market Performance
        6.7.3 Market Breakup by Prescriber
        6.7.4 Market Breakup by Public and Private Sectors
        6.7.5 Market Forecast
    6.8 Tetanus Toxoid Vaccine Market
        6.8.1 Vaccine Overview and Epidemiology
        6.8.2 Market Performance
        6.8.3 Market Breakup by Prescriber
        6.8.4 Market Breakup by Public and Private Sectors
        6.8.5 Market Forecast
    6.9 Hepatitis A Vaccine Market
        6.9.1 Vaccine Overview and Epidemiology
        6.9.2 Market Performance
        6.9.3 Market Breakup by Prescriber
        6.9.4 Market Breakup by Public and Private Sectors
        6.9.5 Market Forecast
    6.10 Rubella Vaccine Market
        6.10.1 Vaccine Overview and Epidemiology
        6.10.2 Market Performance
        6.10.3 Market Breakup by Prescriber
        6.10.4 Market Breakup by Public and Private Sectors
        6.10.5 Market Forecast
    6.11 DPT Vaccine Market
        6.11.1 Vaccine Overview and Epidemiology
        6.11.2 Market Performance
        6.11.3 Market Breakup by Prescriber
        6.11.4 Market Breakup by Public and Private Sectors
        6.11.5 Market Forecast
   6.12 Polio Vaccine Market
        6.12.1 Vaccine Overview and Epidemiology
        6.12.2 Market Performance
        6.12.3 Market Breakup by Prescriber
        6.12.4 Market Breakup by Public and Private Sectors
        6.12.5 Market Forecast
    6.13 MMR Vaccine Market
        6.13.1 Vaccine Overview and Epidemiology
        6.13.2 Market Performance
        6.13.3 Market Breakup by Prescriber
        6.13.4 Market Breakup by Public and Private Sectors
        6.13.5 Market Forecast
    6.14 Rotavirus Vaccine Market
        6.16.1 Vaccine Overview and Epidemiology
        6.16.2 Market Performance
        6.16.3 Market Breakup by Prescriber
        6.16.4 Market Breakup by Public and Private Sectors
        6.16.5 Market Forecast
    6.15 Hepatitis B Vaccine Market
        6.15.1 Vaccine Overview and Epidemiology
        6.15.2 Market Performance
        6.15.3 Market Breakup by Prescriber
        6.15.4 Market Breakup by Public and Private Sectors
        6.15.5 Market Forecast
    6.16 Pneumococcal Vaccine Market
        6.16.1 Vaccine Overview and Epidemiology
        6.16.2 Market Performance
        6.16.3 Market Breakup by Prescriber
        6.16.4 Market Breakup by Public and Private Sectors
        6.16.5 Market Forecast
    6.17 Meningococcal Vaccine Market
        6.17.1 Vaccine Overview and Epidemiology
        6.17.2 Market Performance
        6.17.3 Market Breakup by Prescriber
        6.17.4 Market Breakup by Public and Private Sectors
        6.17.5 Market Forecast
    6.18 Rabies Vaccine Market
        6.18.1 Vaccine Overview and Epidemiology
        6.18.2 Market Performance
        6.18.3 Market Breakup by Prescriber
        6.18.4 Market Breakup by Public and Private Sectors
        6.18.5 Market Forecast
    6.19 HPV Vaccine Market
        6.19.1 Vaccine Overview and Epidemiology
        6.19.2 Market Performance
        6.19.3 Market Breakup by Prescriber
        6.19.4 Market Breakup by Public and Private Sectors
        6.19.5 Market Forecast
7   SWOT Analysis
    7.1    Strengths
    7.2    Weaknesses
     7.3    Opportunities
    7.4    Threats
8   Value Chain Analysis
    8.1    Exploratory stage
    8.2    Preclinical and Clinical Development
     8.3    Regulatory Approval
    8.4    Manufacturing
    8.5    Distributors
    8.6    Pharmacies
9   Porter’s Five Forces Analysis 
    9.1    Overview
    9.2    Bargaining Power of Buyers
     9.3    Bargaining Power of Suppliers
    9.4    Degree of Competition
    9.5    Threat of New Entrants
    9.6    Threat of Substitutes
10. Competitive Landscape
  10.1    Market Structure
  10.2    Market Share of Key Players
11. Pricing Analysis
12. Regulatory Framework       
13. Key Player Profiles

    13.1 GlaxoSmithKline
    13.2 Sanofi Aventis
    13.3 Pfizer
    13.4 Novartis
    13.5 Serum Institute of India
    13.6 Panacea Biotech
    13.7 VHB Lifesciences
    13.8 Zydus Cadila
    13.9 MSD
    13.10 Shantha Biotech


List of Figures

Figure 1: Vaccine Development and Introduction 
Figure 2: Comparison of Global and Indian Vaccine Market
Figure 3: India: Vaccine Market: Sales Value (in Billion INR), 2009 - 2016
Figure 4: India: Vaccine Market: Value Breakup by Segment (in %), 2016
Figure 5: India: Monovalent Vaccine Market: Value Breakup by Vaccine Type (in %), 2016
Figure 6: India: Combined Vaccine Market: Value Breakup by Vaccine Type  (in %), 2016
Figure 7: India: Vaccine Market: Value Breakup by Key Players (in %), 2016
Figure 8: India: BCG Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 9: India: BCG Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 10: India: BCG Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 11: India: BCG Vaccine Market: Breakup by Sector (in %), 2016
Figure 12: India: BCG Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 13: India: HIB Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 14: India: HIB Vaccine Market: Doses Administered (in ‘000), 2009 - 2016
Figure 15: India: HIB Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 16: India: HIB Vaccine Market: Breakup by Sector (in %), 2016
Figure 17: India: HIB Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 18: India: Influenza Vaccine Market: Sales value (in Million INR), 2010 - 2014
Figure 19: India: Influenza Vaccine Market: Doses Administered (in Million), 2010 - 2014
Figure 20: India: Influenza Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 21: India: Influenza Vaccine Market: Breakup by Sector (in %), 2016
Figure 22: India: Influenza Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 23: India: Varicella Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 24: India: Varicella Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 25: India: Varicella Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 26: India: Varicella Vaccine Market: Breakup by Sector (in %), 2016
Figure 27: India: Varicella Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 28: India: Typhoid Vaccine Market: Sales value (in Million INR), 2009 - 2016
Figure 29: India: Typhoid Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 30: India: Typhoid Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 31: India: Typhoid Vaccine Market: Breakup by Sector (in %), 2016
Figure 32: India: Typhoid Vaccine Market: Sales Value Forecast (in Millions INR), 2017 - 2022
Figure 33: India: JE Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 34: India: JE Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 35: India: JE Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 36: India: JE Vaccine Market: Breakup by Sector (in %), 2016
Figure 37: India: JE Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 38: India: Measles Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 39: India: Measles Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 40: India: Measles Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 41: India: Measles Vaccine Market: Breakup by Sector (in %), 2016
Figure 42: India: Measles Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 43: India: TT Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 44: India: TT Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 45: India: TT Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 46: India: TT Vaccine Market: Breakup by Sector (in %), 2016
Figure 47: India: TT Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 48: India: Hepatitis A Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 49: India: Hepatitis A Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 50: India: Hepatitis A Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 51: India: Hepatitis A Vaccine Market: Breakup by Sector (in %), 2016
Figure 52: India: Hepatitis A Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 53: India: Rubella Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 54: India: Rubella Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 55: India: Rubella Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 56: India: Rubella Vaccine Market: Breakup by Sector (in %), 2016
Figure 57: India: Rubella Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 57: India: DPT Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 58: India: DPT Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 59: India: DPT Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 60: India: DPT Vaccine Market: Breakup by Sector (in %), 2016
Figure 61: India: DPT Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 62: India: Polio Vaccine: Incidence of Polio, 2009 - 2016
Figure 63: India: Polio Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 64: India: Polio Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 65: India: Polio Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 66: India: Polio Vaccine Market: Breakup by Sector (in %), 2016
Figure 67: India: Polio Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 68: India: MMR Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 69: India: MMR Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 70: India: MMR Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 71: India: MMR Vaccine Market: Breakup by Sector (in %), 2016
Figure 72: India: MMR Vaccine Market: Sales Value Forecast (in INR Million), 2017 - 2022
Figure 73: India: Rotavirus Vaccine Market: Sales Value (in Million INR), 2010-2014
Figure 74: India: Rotavirus Vaccine Market: Doses Administered (in Million), 2010-2014
Figure 75: India: Rotavirus Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 76: India: Rotavirus Vaccine Market: Breakup by Sector (in %), 2016
Figure 77: India: Rotavirus Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 78: India: Hepatitis B Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 79: India: Hepatitis B Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 80: India: Hepatitis B Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 81: India: Hepatitis B Vaccine Market: Breakup by Sector (in %), 2016
Figure 82: India: Hepatitis B Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 83: India: Pneumonia Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 84: India: Pneumonia Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 85: India: Pneumonia Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 86: India: Pneumonia Vaccine Market: Breakup by Sector (in %), 2016
Figure 87: India: Pneumonia Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 88: India: Meningococcal Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 89: India: Meningococcal Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 90: India: Meningococcal Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 91: India: Meningococcal Vaccine Market: Breakup by Sector (in %), 2016
Figure 92: India: Meningococcal Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 93: India: Rabies Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 94: India: Rabies Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 95: India: Rabies Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 96: India: Rabies Vaccine Market: Breakup by Sector (in %), 2016
Figure 97: India: Rabies Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022
Figure 98: India: HPV Vaccine Market: Sales Value (in Million INR), 2009 - 2016
Figure 99: India: HPV Vaccine Market: Doses Administered (in Million), 2009 - 2016
Figure 100: India: HPV Vaccine Market: Breakup by Prescriber (in %), 2016
Figure 101: India: HPV Vaccine Market: Breakup by Sector (in %), 2016
Figure 102: India: HPV Vaccine Market: Sales Value Forecast (in Million INR), 2017 - 2022

 

List of Tables

Table 1: India: Vaccine Market Overview
Table 2: India: Monovalent Vaccine Market: Value Breakup by Vaccine, 2016 and 2022
Table 3: India: Combined Vaccine Market: Value Breakup by Vaccine, 2016 and 2022
Table 4: India: Top Vaccine Manufacturers, 2016
 


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled “GCC Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the generic drugs market in the GCC reached a value of nearly US$ 1,550 Million in 2016, exhibiting a CAGR of 15% during 2009-2016.


US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s new report titled “US Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the US generic injectables market reached a value of US$ 10 Billion in 2016, exhibiting a CAGR of more than 9% during 2009-2016.


Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022

According to IMARC Group’s latest report titled, “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global generic injectables market reached a value of more than US$ 23 Billion in 2016, exhibiting a CAGR of around 9% during 2009-...


Global Biopharmaceutical Manufacturing Market Report 2017-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2017-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2017-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2017-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...